Saptak Chem: No Deviation in Use of Preferential Issue Proceeds
Saptak Chem And Business Ltd 路 Others (Uncategorized) 路 01 Aug 2026, 11:55 pm
Saptak Chem: No Deviation in Use of Preferential Issue Proceeds Saptak Chem and Business Limited confirmed no deviation in utilizing funds from its preferential issue of convertible warrants for the quarter ended 30 Jun'26. The company raised Rs 4.20 crore via the issuance of 40 lakh warrants at Rs 10.50 each. As of the reporting date, it has received Rs 1.05 crore (25% consideration) and utilized Rs 1.57 crore towards working capital requirements. The Audit Committee reviewed the utilization statement and noted no variations from the stated objectives.
Original exchange filing (PDF)
More announcements from Saptak Chem And Business Ltd
- Un-Audited Financial Results along with Statutory Auditors Limited Review Report for the Quarter ended September 30, 2026 路 29 Oct 2026
- Un-Audited Financial Results along with Auditors Limited Review Report for the Quarter ended September 30, 2026 路 29 Oct 2026
- Saptak Chem And Business Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/10/2026 ,inter alia, to consider and approve Results for Quarter .... 路 24 Oct 2026
- AGM Voting Results 路 31 Aug 2026
- Proceedings of AGM 路 29 Aug 2026
- Corringendum to AGM 路 18 Aug 2026
- Annual Report 2025-26 路 06 Aug 2026
- Notice of AGM 路 06 Aug 2026
